Search Results 161-170 of 24352 for B cell lymphomas
... B-cell Lymphoma (R/R DLBCL). Rochester, Minn. Study B9991011 is a multi-center, international, randomized, open label, 2 component (Phase 1b followed by ...
Cutaneous t-cell lymphoma, B-cell lymphoma, T-cell lymphoma, Follicular lymphoma, Sezary syndrome, Peripheral T-cell ly...mphoma. Show more areas of focus ...
Lenalidomide in Improving Immune Response to Vaccine Therapy in Patients With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Monoclonal B Cell ...
... B-cell lymphoma, T-cell lymphomas remain relatively understudied. Dr ... cell lymphoma and the biologic consequences of these abnormalities in the tumor cells.
... Cells Predicts Survival Post-Autologous Stem Cell Transplantation in Lymphomas. ... cell therapy for large B-cell lymphoma: the Mayo Clinic experience. Leuk ...
Primary CNS lymphoma treatment (PDQ) — Patient version https://www.cancer.gov/types/lymphoma/patient/primary-cns-lymphoma-treatment-pdq. ... B-cell lymphoma.
... B-cell lymphoma, a common type of non-Hodgkin's lymphoma. This research focuses on identifying specific criteria and how they impact trial exclusion in ...
This therapy was first approved by the U.S. Food and Drug Administration in 2017 to treat B-cell lymphoma and leukemia. The process of making and administering ...
1 cells administered following a conditioning lymphodepletion regimen in diffuse large B cell lymphoma (DLBCL) subjects who failed at least two lines of ...
... B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma. Print ... B-cell chronic lymphocytic leukemia or small lymphocytic lymphoma.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!